文献速递胸部肿瘤放疗放疗物理与技术

非小细胞肺癌放化疗后心脏亚结构剂量与体力活动及生活质量变化:CLARITY 前瞻性研究二次分析

Cardiac substructure radiotherapy dose and changes in physical activity and quality of life after chemoradiotherapy for NSCLC: a secondary analysis of the CLARITY prospective study.
PubMed 文献 · Clin Transl Radiat Oncol · 2025-11-12

该研究基于 CLARITY 前瞻性队列中 122 例接受常规分割同步放化疗的非小细胞肺癌患者,分析 30 项心脏亚结构剂量参数与患者报告结局变化的关系。结果显示体力活动、疲乏及呼吸困难评分从基线至放疗结束恶化,之后恢复至基线水平;校正多重比较后,未发现心脏剂量参数与这些变化显著相关。

要点

  • 患者报告的体力活动、疲乏和呼吸困难在放疗结束时恶化,随后恢复至基线。
  • 校正多重比较后,30 项心脏亚结构剂量参数与结局恶化均无显著关联。
  • 研究提示心脏剂量并非这些患者报告结局变化的独立相关因素。

核心结论

  • 患者报告结局从基线至胸部放化疗结束恶化,随后恢复至基线水平。
  • 心脏放疗剂量参数与患者报告的体力活动、疲乏或呼吸困难变化无显著关联。

研究设计与样本

  • 研究为 CLARITY 多机构纵向前瞻性队列研究(NCT04305613)的二次分析,纳入 122 例接受常规分割放疗(1.8-2 Gy/次)同步化疗的非小细胞肺癌患者。
  • 预设选取 30 项心脏剂量参数(全心、左心室、右心室、左心房、右心房及左前降支的平均剂量、最大剂量、V5Gy、V15Gy、V30Gy),采用 LASSO 回归及广义估计方程重复测量线性回归分析。

主要发现

  • 中位年龄 67 岁,57% 为男性,41% 有心血管疾病史;全心平均剂量中位数 9 Gy,全心最大剂量 64 Gy,左前降支 V15Gy 为 1%。
  • Godin 体力活动(p=0.0499)、FACIT-疲乏(p<0.001)和 FACIT-呼吸困难(p=0.0037)评分从基线至放疗结束恶化,之后恢复至基线水平。
  • 多变量分析校正多重比较后,未发现任何心脏剂量参数与体力活动、疲乏或呼吸困难恶化显著相关(p>0.05)。

临床怎么用

  • 对于接受同步放化疗的非小细胞肺癌患者,应预期其体力活动、疲乏和呼吸困难在治疗结束时短暂恶化并在后续恢复。
  • 基于本分析,心脏亚结构剂量参数未显示与上述患者报告结局变化独立相关,但仍需结合其他心脏毒性终点综合评估。

局限性

  • 原文未报告局限性内容。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: The objective was to assess associations between cardiac substructure dose and changes in patient-reported outcomes (PROs) post-chemoradiotherapy for non-small cell lung cancer (NSCLC). METHODS AND MATERIALS: The study population was derived from CLARITY (NCT04305613), a multi-institutional longitudinal prospective cohort study. Patients treated with conventionally fractionated radiotherapy (1.8-2 Gy per fraction) with concurrent chemotherapy completed physical activity (Godin) and quality of life (FACIT-Fatigue and Dyspnea) questionnaires at baseline, completion of radiotherapy, 6 and 12 months post-radiotherapy. Thirty cardiac dosimetric parameters were a priori selected from centrally contoured radiotherapy plans: mean dose, maximum dose, volume receiving ≥ 5 Gy (V5Gy), V15Gy, and V30Gy to the whole heart, left ventricle, right ventricle, left atrium, right atrium, and left anterior descending coronary artery, and applied to a LASSO regression model to further define variable importance. Associations between cardiac radiation dose metrics and changes in PROs were assessed using repeated-measures linear regression via generalized estimating equations with correction for multiple testing. RESULTS: In a subcohort of 122 patients, the median age was 67 years, 57% were male, and 41% had prevalent cardiovascular disease. Median whole heart mean dose was 9 Gy, whole heart maximum dose was 64 Gy, and LAD V15Gy was 1%. Godin physical activity (p = 0.0499), FACIT-Fatigue (p < 0.001), and FACIT-Dyspnea scores (p = 0.0037) worsened from baseline to end of radiotherapy, then recovered to baseline levels thereafter. In multivariable analysis and after adjusting for multiple comparisons, no cardiac dose metric was significantly associated with a worsening in patient-reported physical activity, fatigue or dyspnea (p > 0.05). CONCLUSIONS: PROs worsened from baseline to the end of thoracic chemoradiotherapy, then recovered to baseline levels. Cardiac radiation dose metrics were not associated with these changes.

来源:Clin Transl Radiat Oncol,查看原文。版权归原作者所有。

引用

  1. Yegya-Raman N, Ko K, Han IS, et al. Cardiac substructure radiotherapy dose and changes in physical activity and quality of life after chemoradiotherapy for NSCLC: a secondary analysis of the CLARITY prospective study. Clin Transl Radiat Oncol. 2025. PMID: 41334108. doi:10.1016/j.ctro.2025.101070

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。